Nanobody Repertoire Retains Efficacy Against Rapidly Evolving SARS-CoV-2 Variants
Nanobodies generated against the ancestral SARS-CoV-2 spike protein remain effective in neutralizing rapidly evolving variants, including omicron BA.4/BA.5, and can be combined synergistically to enhance potency.